466 One study proposed a novel mechanism wherein postprandial GLP-1 release, under normal physiological conditions, inhibits the activity of chemosensory cells in the carotid body, thereby counteracting sympathetic excitability mediated by elevated blood glucose or insulin levels
A smores-inspired elevated Greek yogurt that tastes more like a pudding
Clinical evidence: Any lab results, such as A1C levels, blood pressure readings, or BMI measurements, that support the necessity of the medication
GLP-1 therapy may help by reducing the biological drive to overeat
This antioxidant has been found to improve glucose uptake and may enhance GLP-1 response through mitochondrial and insulin-signaling pathways
Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) that was recently approved by the FDA for the treatment of type 2 diabetes